Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous azithromycin versus intravenous erythromycin before urgent endoscopy for upper gastrointestinal bleeding
2016-003339-39Phase 3Active
- Sponsor
- JOSÉ MAR�A PALAZÓN AZOR�N
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in upper gastrointestinal bleeding (UGIB) comparing Intravenous azithromycin with Intravenous erythromycin (2 arms). Primary endpoint: Diagnostic performance. Started Apr 2017; status: active.
02
Drugs
azithromycinerythromycin
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on 2016-003339-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003339-39.